tradingkey.logo

Utah Medical Products Inc

UTMD
56.610USD
+0.010+0.02%
收盘 12/22, 16:00美东报价延迟15分钟
181.38M总市值
15.98市盈率 TTM

Utah Medical Products Inc

56.610
+0.010+0.02%

关于 Utah Medical Products Inc 公司

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Utah Medical Products Inc简介

公司代码UTMD
公司名称Utah Medical Products Inc
上市日期Dec 01, 1982
CEOCornwell (Kevin L)
员工数量155
证券类型Ordinary Share
年结日Dec 01
公司地址7043 S 300 West
城市MIDVALE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编84070
电话18015215301
网址http://www.utahmed.com
公司代码UTMD
上市日期Dec 01, 1982
CEOCornwell (Kevin L)

Utah Medical Products Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-1.05%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Kevin Timken
Mr. Kevin Timken
Director
Director
--
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.24K
-1.05%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Kevin Timken
Mr. Kevin Timken
Director
Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Gynecology/Electrosurgery/Urology
4.81M
48.30%
Neonatal
2.10M
21.12%
Blood Pressure Monitoring and Accessories
2.02M
20.29%
Obstetrics
1.02M
10.30%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Gynecology/Electrosurgery/Urology
4.81M
48.30%
Neonatal
2.10M
21.12%
Blood Pressure Monitoring and Accessories
2.02M
20.29%
Obstetrics
1.02M
10.30%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Brandes Investment Partners, L.P.
10.55%
Renaissance Technologies LLC
6.27%
Dimensional Fund Advisors, L.P.
6.24%
Cornwell (Kevin L)
5.88%
The Vanguard Group, Inc.
5.48%
其他
65.57%
持股股东
持股股东
占比
Brandes Investment Partners, L.P.
10.55%
Renaissance Technologies LLC
6.27%
Dimensional Fund Advisors, L.P.
6.24%
Cornwell (Kevin L)
5.88%
The Vanguard Group, Inc.
5.48%
其他
65.57%
股东类型
持股股东
占比
Investment Advisor
41.26%
Investment Advisor/Hedge Fund
19.06%
Hedge Fund
8.74%
Individual Investor
7.14%
Research Firm
0.70%
Bank and Trust
0.18%
Pension Fund
0.05%
Insurance Company
0.04%
其他
22.83%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
243
2.27M
70.80%
-636.90K
2025Q2
249
2.53M
77.79%
-699.23K
2025Q1
251
2.54M
78.08%
-658.65K
2024Q4
245
2.63M
77.47%
-634.89K
2024Q3
233
2.73M
78.80%
-558.16K
2024Q2
224
2.74M
78.05%
-528.35K
2024Q1
214
2.81M
78.59%
-191.73K
2023Q4
203
2.83M
78.07%
-204.85K
2023Q3
194
2.97M
81.82%
-7.55K
2023Q2
183
2.95M
81.20%
-24.79K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Brandes Investment Partners, L.P.
333.20K
10.39%
+61.88K
+22.81%
Aug 31, 2025
Renaissance Technologies LLC
213.31K
6.65%
-4.40K
-2.02%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
197.47K
6.16%
+4.51K
+2.34%
Jun 30, 2025
Cornwell (Kevin L)
188.47K
5.88%
--
--
Mar 03, 2025
The Vanguard Group, Inc.
177.10K
5.52%
+730.00
+0.41%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
157.93K
4.93%
+12.53K
+8.61%
Jun 30, 2025
Hotchkis and Wiley Capital Management, LLC
111.95K
3.49%
+10.31K
+10.14%
Jun 30, 2025
Minerva Advisors LLC
93.06K
2.9%
+6.16K
+7.08%
Jun 30, 2025
Geode Capital Management, L.L.C.
114.82K
3.58%
+7.04K
+6.53%
Jun 30, 2025
State Street Investment Management (US)
70.12K
2.19%
-10.03K
-12.51%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Acquirers Small and Micro Deep Value ETF
0.89%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
Royce Quant Small-Cap Quality Value ETF
0.2%
WisdomTree U.S. SmallCap Dividend Fund
0.06%
iShares Micro-Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Global X Russell 2000 ETF
0.01%
DFA Dimensional US Small Cap Value ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
查看更多
Acquirers Small and Micro Deep Value ETF
占比0.89%
JPMorgan Fundamental Data Science Small Core ETF
占比0.21%
Royce Quant Small-Cap Quality Value ETF
占比0.2%
WisdomTree U.S. SmallCap Dividend Fund
占比0.06%
iShares Micro-Cap ETF
占比0.03%
Avantis US Small Cap Equity ETF
占比0.02%
Global X Russell 2000 ETF
占比0.01%
DFA Dimensional US Small Cap Value ETF
占比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%

分红派息

近5年累计派现 27.29M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jul 29, 2025
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Oct 02, 2025 going ex on Sep 17, 2025
Sep 17, 2025
Oct 02, 2025
Sep 17, 2025
May 08, 2025
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Jul 03, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jul 03, 2025
Jun 16, 2025
Feb 04, 2025
UTMD.NB Final Cash Dividend of gross USD 0.305 paid on Apr 03, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 03, 2025
Mar 14, 2025
Dec 11, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.305 paid on Jan 03, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 03, 2025
Dec 16, 2024
Aug 02, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Oct 04, 2024 going ex on Sep 20, 2024
Sep 20, 2024
Oct 04, 2024
Sep 20, 2024
May 07, 2024
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 06, 2024
UTMD.NB Final Cash Dividend of gross USD 0.3 paid on Apr 03, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 03, 2024
Mar 14, 2024
Oct 31, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.3 paid on Jan 03, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 03, 2024
Dec 14, 2023
Aug 02, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Oct 03, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 03, 2023
Sep 14, 2023
May 10, 2023
UTMD.NB Interim Cash Dividend of gross USD 0.295 paid on Jul 06, 2023 going ex on Jun 15, 2023
Jun 16, 2023
Jul 06, 2023
Jun 15, 2023
查看更多

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Utah Medical Products Inc的前五大股东是谁?

Utah Medical Products Inc 的前五大股东如下:
Brandes Investment Partners, L.P.持有股份:333.20K,占总股份比例:10.39%。
Renaissance Technologies LLC持有股份:213.31K,占总股份比例:6.65%。
Dimensional Fund Advisors, L.P.持有股份:197.47K,占总股份比例:6.16%。
Cornwell (Kevin L)持有股份:188.47K,占总股份比例:5.88%。
The Vanguard Group, Inc.持有股份:177.10K,占总股份比例:5.52%。

Utah Medical Products Inc的前三大股东类型是什么?

Utah Medical Products Inc 的前三大股东类型分别是:
Brandes Investment Partners, L.P.
Renaissance Technologies LLC
Dimensional Fund Advisors, L.P.

有多少机构持有Utah Medical Products Inc(UTMD)的股份?

截至2025Q3,共有243家机构持有Utah Medical Products Inc的股份,合计持有的股份价值约为2.27M,占公司总股份的70.80%。与2025Q2相比,机构持股有所增加,增幅为-6.99%。

哪个业务部门对Utah Medical Products Inc的收入贡献最大?

在FY2025Q2,Gynecology/Electrosurgery/Urology业务部门对Utah Medical Products Inc的收入贡献最大,创收4.81M,占总收入的48.30%。
KeyAI